BGS continues to expand: Following around ten months of construction, we have now taken a new logistics hall into operation at the Bruchsal location and with this addition, more than doubled the previous space.
The market for in-vitro diagnostics, laboratory supplies and medical devices is growing and for several years now, it has ensured a steadily rising demand for sterilization capacities. In addition to the gamma irradiation facility at the headquarters in Wiehl (North Rhine-Westphalia), BGS has been operating a new, ultra-modern plant at the location in Bruchsal since 2018 to manage these growing capacities. Its activity has increased continuously since then. “Of course, the increased output requires more logistics space, which led us to start the planning of a new storage hall on the existing premises of the company grounds already at the end of 2019,” explains Managing Director Dr. Andreas Ostrowicki. The start of construction of the new building in April 2020 was preceded by extensive demolition works of the old building as well as earthworks.
Further increase in expendable medical items during the corona pandemic
“Since the beginning of the corona pandemic, the need for laboratory consumables and primary packaging material for the pharmaceutical industry has risen significantly once again, and correspondingly, the need for sterilization capacities,” continues Andreas Ostrowicki. “Similarly, the increased demand for single-use products required for the production of corona vaccines is clearly evident. Through the construction of the new hall, we have created urgently needed storage space to cater to the further expansion of these capacities. Furthermore, the expansion allows an even more efficient handling of the flow of goods, while ensuring that regulatory requirements are fulfilled, for example, the separation of non-irradiated and irradiated products.”
